印度通过增加当地生产和测试量, 推出500 克罗雷计划, 削减医疗设备进口。 India launches ₹500 crore plan to cut medical device imports by boosting local production and testing.

印度政府在2026年1月10日前提出提案, 以降低70%对进口医疗设备的依赖率。 India’s government has launched a ₹500 crore initiative to reduce its 70% reliance on imported medical devices, inviting proposals by January 10, 2026. 该计划由药品部于2024年11月宣布,包括两个部分:为30家公司提供180亿卢比的补贴,用于生产必需的组件和原材料,并支持10-20%的项目成本,在支出后可退还10亿卢比;以及110亿卢比用于资助临床测试,为患者试验提供高达500万卢比,动物研究为2.5亿卢比,以及用于体外诊断评估的100万卢比. The scheme, announced in November 2024 by the Department of Pharmaceuticals, includes two parts: ₹180 crore in subsidies for up to 30 companies to produce essential components and raw materials, with support of 10–20% of project costs—up to ₹10 crore—reimbursable after spending; and ₹110 crore to fund clinical testing, offering up to ₹5 crore for patient trials, ₹2.5 crore for animal studies, and ₹1 crore for in-vitro diagnostic evaluations. 这项努力旨在促进国内制造业,确保供应稳定,降低成本,并促进保健技术的创新。 The effort aims to boost domestic manufacturing, ensure supply stability, lower costs, and promote innovation in healthcare technology.